Ruth Namuyinga

Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial

Jörge E. Cortes, Samer K. Khaled, Giovanni Martinelli et al. · The Lancet Oncology · 2019 · 465 citations

Hematological Malignancy, Medicine, Hematology +5

Viral Nucleic Acid Testing (NAT) and OPO-Level Disposition of High-Risk Donor Organs

Lauren M. Kucirka, Charles Alexander, Ruth Namuyinga et al. · American Journal of Transplantation · 2009 · 69 citations · Full text

Organ Donation, Solid Organ Transplantation, Organ Procurement +20

Formal Policies and Special Informed Consent Are Associated with Higher Provider Utilization of CDC High-Risk Donor Organs

Lauren M. Kucirka, Ruth Namuyinga, Colleen F. Hanrahan et al. · American Journal of Transplantation · 2009 · 59 citations

Formal Policies, Organ Donation, Organ Procurement +8

Provider Utilization of High-Risk Donor Organs and Nucleic Acid Testing: Results of Two National Surveys

Lauren M. Kucirka, Ruth Namuyinga, Colleen F. Hanrahan et al. · American Journal of Transplantation · 2009 · 58 citations · Full text

Promising Practices for Achieving Patient-centered Hospital Care

Hanan Aboumatar, Bickey H. Chang, Jad Al Danaf et al. · Medical Care · 2015 · 57 citations